Androxal / Enclomiphene 25mg

Description

Androxal 25mg is the full-strength therapeutic dose of Phalanx’s pharmaceutical-grade Enclomiphene Citrate — the selective oestrogen receptor modulator that restores your endogenous testosterone axis without suppressing it. At 25mg daily, this dose has been the benchmark in clinical hypogonadism trials, consistently driving total testosterone into the mid-to-high-normal range while preserving — and in many cases improving — spermatogenesis. Enclomiphene achieves this by acting as a competitive antagonist at hypothalamic and pituitary oestrogen receptors, forcing a sustained increase in GnRH pulsatility and downstream LH/FSH output. The result is your own testes being driven to produce testosterone physiologically. This is the standard dose for PCT, for men transitioning off suppressive cycles, and for those choosing not to inject. It’s also increasingly used as a long-term alternative to exogenous TRT — keeping the axis intact, the testes functional, and fertility preserved. Every tablet is independently tested to 99%+ purity by Puralytix. Monitor LH, FSH, total testosterone, and oestradiol at baseline and 6–8 weeks into therapy to confirm response and adjust dose if needed. The majority of men with secondary hypogonadism reach mid-normal testosterone range within 4–8 weeks at this dose. Phalanx’s Enclomiphene is batch-tested for purity and dose accuracy — pharmaceutical credentials without the prescription price.